Similar articles

• Separate influences of insulin and hyperglycemia on hepatic drug metabolism in mice with genetic and chemically induced diabetes mellitus.

  Knodell RG, Handwerger BS, Morley JE, Levine AS, Brown DM. Knodell RG, et al. J Pharmacol Exp Ther. 1984 Jul;230(1):256-62. J Pharmacol Exp Ther. 1984. PMID: 6379147
• Activities of hepatic and extrahepatic microsomal mixed function oxidase enzymes in diabetic and gonadectomized-diabetic rats.

  Al-Turk WA, Stohs SJ, Roche EB. Al-Turk WA, et al. Gen Pharmacol. 1981;12(5):345-50. doi: 10.1016/0306-3623(81)90088-4. Gen Pharmacol. 1981. PMID: 7286602 No abstract available.
• Induction of drug metabolizing enzymes in the liver of diabetic mice.

  Rouer E, Mahu JL, Columelli S, Dansette P, Leroux JP. Rouer E, et al. Biochimie. 1982 Oct;64(10):961-7. doi: 10.1016/s0300-9084(82)80360-x. Biochimie. 1982. PMID: 6295511
• Fetal and neonatal development of the microsomal monooxygenase system.

  Short CR. Short CR. Drug Metab Rev. 1976;5(1):1-42. Drug Metab Rev. 1976. PMID: 802085 Review. No abstract available.
• Developmental aspects of the hepatic cytochrome P450 monooxygenase system.

  Neims AH, Warner M, Loughnan PM, Aranda JV. Neims AH, et al. Annu Rev Pharmacol Toxicol. 1976;16:427-45. doi: 10.1146/annurev.pa.16.040176.002235. Annu Rev Pharmacol Toxicol. 1976. PMID: 820239 Review. No abstract available.